Cargando…

The Effect of Oral Isotretinoin Therapy on Meibomian Gland Characteristics in Patients with Acne Vulgaris

INTRODUCTION: The aim of the study was to determine the effect of oral isotretinoin therapy on the functional and morphological condition of the anterior segment of the eye, with particular emphasis on the meibomian glands. METHODS: Twenty-four patients (48 eyes) with a diagnosis of acne vulgaris we...

Descripción completa

Detalles Bibliográficos
Autores principales: Zakrzewska, Aleksandra, Wiącek, Marta P., Słuczanowska-Głąbowska, Sylwia, Safranow, Krzysztof, Machalińska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287853/
https://www.ncbi.nlm.nih.gov/pubmed/37301783
http://dx.doi.org/10.1007/s40123-023-00737-6
_version_ 1785061958636011520
author Zakrzewska, Aleksandra
Wiącek, Marta P.
Słuczanowska-Głąbowska, Sylwia
Safranow, Krzysztof
Machalińska, Anna
author_facet Zakrzewska, Aleksandra
Wiącek, Marta P.
Słuczanowska-Głąbowska, Sylwia
Safranow, Krzysztof
Machalińska, Anna
author_sort Zakrzewska, Aleksandra
collection PubMed
description INTRODUCTION: The aim of the study was to determine the effect of oral isotretinoin therapy on the functional and morphological condition of the anterior segment of the eye, with particular emphasis on the meibomian glands. METHODS: Twenty-four patients (48 eyes) with a diagnosis of acne vulgaris were involved in the survey. All patients underwent a thorough ophthalmological examination at three time points: before therapy, 3 months after the start of therapy, and 1 month after the completion of isotretinoin therapy. The physical examination included the following elements: blink rate, analysis of the lid margin abnormality score (LAS), tear film break-up time (TFBUT) and Schirmer’s test, meibomian gland loss (MGL), and the evaluation of the meibum quality score (MQS) and meibum expressibility score (MES). Additionally, the total score of an ocular surface disease index (OSDI) questionnaire was analysed. RESULTS: In comparison with pretreatment values, significant increases in OSDI during and after the treatment (p = 0.003 and p = 0.004, respectively) were observed. Substantial deterioration during the treatment was observed for MGL (p < 0.0001), MQS (p < 0.001) and LAS (p < 0.0001), while an improvement in those parameters after isotretinoin cessation was observed (p = 0.006, p = 0.02 and p = 0.0003, respectively). The frequency of using artificial eye drops was positively associated with MGL during (Spearman’s rank correlation coefficient (Rs) =  + 0.31; p = 0.03) and after the cessation of the therapy (Rs =  + 0.28; p = 0.04). Meibomian gland atrophy correlated significantly with MQS during (Rs =  + 0.29; p = 0.04) and after treatment (Rs =  + 0.38; p = 0.008). The decrease in TFBUT values correlated with increased LAS (Rs = − 0.31; p = 0.03) during the course of isotretinoin usage. We found no changes in Schirmer's test or blink rates. CONCLUSION: Isotretinoin therapy leads to increased ocular complaints related to lipid tear film component dysfunction. This is due to reversible changes in meibomian gland morphology and function observed during drug usage.
format Online
Article
Text
id pubmed-10287853
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-102878532023-06-24 The Effect of Oral Isotretinoin Therapy on Meibomian Gland Characteristics in Patients with Acne Vulgaris Zakrzewska, Aleksandra Wiącek, Marta P. Słuczanowska-Głąbowska, Sylwia Safranow, Krzysztof Machalińska, Anna Ophthalmol Ther Original Research INTRODUCTION: The aim of the study was to determine the effect of oral isotretinoin therapy on the functional and morphological condition of the anterior segment of the eye, with particular emphasis on the meibomian glands. METHODS: Twenty-four patients (48 eyes) with a diagnosis of acne vulgaris were involved in the survey. All patients underwent a thorough ophthalmological examination at three time points: before therapy, 3 months after the start of therapy, and 1 month after the completion of isotretinoin therapy. The physical examination included the following elements: blink rate, analysis of the lid margin abnormality score (LAS), tear film break-up time (TFBUT) and Schirmer’s test, meibomian gland loss (MGL), and the evaluation of the meibum quality score (MQS) and meibum expressibility score (MES). Additionally, the total score of an ocular surface disease index (OSDI) questionnaire was analysed. RESULTS: In comparison with pretreatment values, significant increases in OSDI during and after the treatment (p = 0.003 and p = 0.004, respectively) were observed. Substantial deterioration during the treatment was observed for MGL (p < 0.0001), MQS (p < 0.001) and LAS (p < 0.0001), while an improvement in those parameters after isotretinoin cessation was observed (p = 0.006, p = 0.02 and p = 0.0003, respectively). The frequency of using artificial eye drops was positively associated with MGL during (Spearman’s rank correlation coefficient (Rs) =  + 0.31; p = 0.03) and after the cessation of the therapy (Rs =  + 0.28; p = 0.04). Meibomian gland atrophy correlated significantly with MQS during (Rs =  + 0.29; p = 0.04) and after treatment (Rs =  + 0.38; p = 0.008). The decrease in TFBUT values correlated with increased LAS (Rs = − 0.31; p = 0.03) during the course of isotretinoin usage. We found no changes in Schirmer's test or blink rates. CONCLUSION: Isotretinoin therapy leads to increased ocular complaints related to lipid tear film component dysfunction. This is due to reversible changes in meibomian gland morphology and function observed during drug usage. Springer Healthcare 2023-06-10 2023-08 /pmc/articles/PMC10287853/ /pubmed/37301783 http://dx.doi.org/10.1007/s40123-023-00737-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Zakrzewska, Aleksandra
Wiącek, Marta P.
Słuczanowska-Głąbowska, Sylwia
Safranow, Krzysztof
Machalińska, Anna
The Effect of Oral Isotretinoin Therapy on Meibomian Gland Characteristics in Patients with Acne Vulgaris
title The Effect of Oral Isotretinoin Therapy on Meibomian Gland Characteristics in Patients with Acne Vulgaris
title_full The Effect of Oral Isotretinoin Therapy on Meibomian Gland Characteristics in Patients with Acne Vulgaris
title_fullStr The Effect of Oral Isotretinoin Therapy on Meibomian Gland Characteristics in Patients with Acne Vulgaris
title_full_unstemmed The Effect of Oral Isotretinoin Therapy on Meibomian Gland Characteristics in Patients with Acne Vulgaris
title_short The Effect of Oral Isotretinoin Therapy on Meibomian Gland Characteristics in Patients with Acne Vulgaris
title_sort effect of oral isotretinoin therapy on meibomian gland characteristics in patients with acne vulgaris
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287853/
https://www.ncbi.nlm.nih.gov/pubmed/37301783
http://dx.doi.org/10.1007/s40123-023-00737-6
work_keys_str_mv AT zakrzewskaaleksandra theeffectoforalisotretinointherapyonmeibomianglandcharacteristicsinpatientswithacnevulgaris
AT wiacekmartap theeffectoforalisotretinointherapyonmeibomianglandcharacteristicsinpatientswithacnevulgaris
AT słuczanowskagłabowskasylwia theeffectoforalisotretinointherapyonmeibomianglandcharacteristicsinpatientswithacnevulgaris
AT safranowkrzysztof theeffectoforalisotretinointherapyonmeibomianglandcharacteristicsinpatientswithacnevulgaris
AT machalinskaanna theeffectoforalisotretinointherapyonmeibomianglandcharacteristicsinpatientswithacnevulgaris
AT zakrzewskaaleksandra effectoforalisotretinointherapyonmeibomianglandcharacteristicsinpatientswithacnevulgaris
AT wiacekmartap effectoforalisotretinointherapyonmeibomianglandcharacteristicsinpatientswithacnevulgaris
AT słuczanowskagłabowskasylwia effectoforalisotretinointherapyonmeibomianglandcharacteristicsinpatientswithacnevulgaris
AT safranowkrzysztof effectoforalisotretinointherapyonmeibomianglandcharacteristicsinpatientswithacnevulgaris
AT machalinskaanna effectoforalisotretinointherapyonmeibomianglandcharacteristicsinpatientswithacnevulgaris